Tranexamic Acid (TXA) Dosing in Primary Total Knee Arthroplasty - Wesley Research Institute
Wesley Research Institute
Donate
Now

The purpose of the study is to evaluate a product called Tranexamic Acid (TXA) and its best use in patients who are undergoing total knee replacement.

Research Objectives

Status

Current

Recruitment

Open

Estimated completion

December 2023

Total participants required

80

Study location

The Wesley Hospital

Study type

Investigator Initiated

Patient group

Patients undergoing total knee replacement surgery (arthroplasty)

About this clinical trial

The purpose of the study is to evaluate a product called Tranexamic Acid (TXA) and its best use in patients who are undergoing total knee replacement. The product is currently used to reduce bleeding during and after surgical procedures. This can lessen the chance of you needing a blood transfusion and may decrease pain, swelling and recovery time following the operation. Tranexamic Acid is already routinely used by surgeons for patients having joint replacements but there is currently no accurate information about the best dosing of the drug to achieve optimal patient outcomes. This study will assess whether different treatment durations will lead to better results for patients.

Eligibility

Do you meet the following criteria?

People undergoing primary unilateral Total Knee Arthroplasty.

Additional information

You can find out more about this clinical trial by visiting the ANZCTR website.

Lead investigator

  • Dr Sue Clark

Clinical trial coordinator

  • Emma Brownrigg

Technical title

A Prospective, Randomised Non-Blinded Pilot Study to Optimise Oral Tranexamic Acid Dosing in Primary Total Knee Arthroplasty (TXA002)

Register your interest

If you would like more information about this clinical trial, please complete the contact form below.

Name(Required)
Address(Required)
DD slash MM slash YYYY
Which if the following accurately describes you?(Required)

Would you like to be updated on the progress of our research?(Required)
I consent to receive updates on Wesley Research Institute news and events, clinical trials, research projects and how to support WRI.
By submitting this form you consent for us to hold your information in accordance with our Privacy Policy
This field is for validation purposes and should be left unchanged.
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram